Biofourmis closes US$100M led by SoftBank to push remote monitoring, digital therapeutics to the forefront of medicine

Biofourmis, a Singapore-based digital therapeutics company, has announced the completion of its US$100 million Series C financing, led by SoftBank Vision Fund II. Existing investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI also joined. This round comes over a year after the firm secured US$35 million in Series B round in May 2019. As […] The post Biofourmis closes US$100M led by SoftBank to push remote monitoring, digital therapeutics to the forefront of medicine appeared first on e27.